Wave Life Sciences Ltd. (FRA:1U5)

Wave Life Sciences Statistics

Total Valuation

FRA:1U5 has a market cap or net worth of EUR 1.07 billion. The enterprise value is 920.62 million.

Market Cap	1.07B
Enterprise Value	920.62M

Important Dates

The next estimated earnings date is Wednesday, March 4, 2026.

Earnings Date	Mar 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	167.18M
Shares Outstanding	n/a
Shares Change (YoY)	+30.63%
Shares Change (QoQ)	+2.29%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	61.91%
Float	73.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.45
PB Ratio	9.44
P/TBV Ratio	10.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.86
EV / Sales	9.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.45

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.15.

Current Ratio	2.51
Quick Ratio	2.40
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.51% and return on invested capital (ROIC) is -51.67%.

Return on Equity (ROE)	-86.51%
Return on Assets (ROA)	-28.33%
Return on Invested Capital (ROIC)	-51.67%
Return on Capital Employed (ROCE)	-87.44%
Revenue Per Employee	323,253
Profits Per Employee	-360,884
Employee Count	288
Asset Turnover	0.36
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.06%
50-Day Moving Average	6.16
200-Day Moving Average	6.60
Relative Strength Index (RSI)	51.39
Average Volume (20 Days)	90

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.64

Income Statement

In the last 12 months, FRA:1U5 had revenue of EUR 93.10 million and -103.93 million in losses. Loss per share was -0.63.

Revenue	93.10M
Gross Profit	-55.72M
Operating Income	-115.87M
Pretax Income	-103.93M
Net Income	-103.93M
EBITDA	-112.88M
EBIT	-115.87M
Loss Per Share	-0.63

Balance Sheet

The company has 167.24 million in cash and 16.85 million in debt, giving a net cash position of 150.38 million.

Cash & Cash Equivalents	167.24M
Total Debt	16.85M
Net Cash	150.38M
Net Cash Per Share	n/a
Equity (Book Value)	112.86M
Book Value Per Share	0.66
Working Capital	110.45M

Cash Flow

In the last 12 months, operating cash flow was -168.21 million and capital expenditures -686,102, giving a free cash flow of -168.90 million.

Operating Cash Flow	-168.21M
Capital Expenditures	-686,102
Free Cash Flow	-168.90M
FCF Per Share	n/a

Margins

Gross margin is -59.86%, with operating and profit margins of -124.46% and -111.64%.

Gross Margin	-59.86%
Operating Margin	-124.46%
Pretax Margin	-111.64%
Profit Margin	-111.64%
EBITDA Margin	-121.25%
EBIT Margin	-124.46%
FCF Margin	n/a

Dividends & Yields

FRA:1U5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.63%
Shareholder Yield	-30.63%
Earnings Yield	-9.75%
FCF Yield	-15.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:1U5 has an Altman Z-Score of 0.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.12
Piotroski F-Score	3